Neoplasms, Squamous Cell clinical trials at University of California Health

• PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

  Sorry, not currently recruiting here

  A Phase 1 dose escalation and expansion study evaluating safety, tolerability and pharmacokinetics of PF-06952229 in adult patients with advanced solid tumors.

  at UCLA

Last updated: April 5, 2021